https://www.selleckchem.com/products/shield-1.html
22 [1.02-1.45]), nonanemic in the first trimester (1.27 [1.09-1.49]), and absence of side effects (3.16 [1.95-5.12]). Conceptual framework was constructed using the emerging themes (i) knowledge-related factors, (ii) behavior-related factors, and (iii) facilitating factors. About three-fourth of the participants were adherent to IFAS. Compliance is directly influenced by the gravida status, anemic status, and absence of side effects. Based on qualitative results, measures to improve palatability and the quality of IFAS are recommended.